DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0024117 | Chronic Obstructive Airway Disease | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0013080 | Down Syndrome | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0007102 | Malignant tumor of colon | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0699790 | Colon Carcinoma | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C1306459 | Primary malignant neoplasm | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0006826 | Malignant Neoplasms | PLA2G2D | 26279 | phospholipase A2 group IID | Q9UNK4 |
C0235974 | Pancreatic carcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0346647 | Malignant neoplasm of pancreas | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0006826 | Malignant Neoplasms | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0030297 | Pancreatic Neoplasm | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0017152 | Gastritis | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0030920 | Peptic Ulcer | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0278701 | Gastric Adenocarcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C1306459 | Primary malignant neoplasm | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0699791 | Stomach Carcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0024623 | Malignant neoplasm of stomach | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0001418 | Adenocarcinoma | A4GNT | 51146 | alpha-1,4-N-acetylglucosaminyltransferase | Q9UNA3 |
C0027877 | Neuronal Ceroid-Lipofuscinoses | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0027651 | Neoplasms | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0006826 | Malignant Neoplasms | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0017665 | Membranous glomerulonephritis | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0026764 | Multiple Myeloma | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0027819 | Neuroblastoma | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0026769 | Multiple Sclerosis | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C1306459 | Primary malignant neoplasm | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024